Jiaqiu Z. Li - Publications

HSF1 promotes malignant phenotype in colorectal cancer via super-enhancer-driven lncRNA EXOSC10-AS1 and targeting HSF1 confers sensitivity to poly (ADP-ribose) polymerase inhibitor Niraparib.

Journal: International journal of biological macromolecules

Published: June 16, 2025

Identification of super-enhancer-based biomarkers for predicting survival and immunotherapy efficacy in colorectal cancer.

Journal: Journal of Cancer

Published: June 10, 2025

Clonal hematopoiesis of indeterminate potential: a multisystem hub bridging hematopoietic dysfunction with non-hematopoietic diseases.

Journal: Military Medical Research

Published: June 04, 2025

Multi-omics and bulk sequencing analyses reveal the roles of prognosis and immune aspects of super-enhancer-induced ZBED2 in pan-cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 22, 2025

The roles of enhancer, especially super-enhancer-driven genes in tumor metabolism and immunity.

Journal: International journal of biological macromolecules

Published: October 16, 2024

Nonsense-mediated mRNA decay inhibits TRAF6-dependent anti-tumor immunity in colorectal cancer.

Journal: Cell reports. Medicine

Published: September 27, 2024

Pan-cancer analysis of enhancer-induced MIR17HG and validation as a SIRT1-promoting factor in colorectal cancer.

Journal: Medical oncology (Northwood, London, England)

Published: August 27, 2024

Pan-cancer analysis reveals the prognostic and immunomodulatory potential of super-enhancer-induced ANGPT2 and experimental validation in colorectal cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 01, 2024

Identification of PANoptosis-based signature for predicting the prognosis and immunotherapy response in AML.

Journal: Heliyon

Published: March 21, 2024

Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer.

Journal: Translational oncology

Published: February 17, 2024

Pan-cancer analysis of super enhancer-induced PRR7-AS1 as a potential prognostic and immunological biomarker.

Journal: Frontiers in genetics

Published: February 07, 2023

Pan-Cancer Analysis of the Roles and Driving Forces of RAB42.

Journal: Biomolecules

Published: October 28, 2022